Protocol ALN-TTR02-007: Expanded Access Protocol of Patisiran for Patients with Hereditary Transthyretin-Mediated Amyloidosis (hATTR Amyloidosis) With Polyneuropathy

Project: Research project

Project Details

StatusFinished
Effective start/end date7/20/177/20/20

Funding

  • Medpace, Inc. (Protocol ALN-TTR02-007)
  • Alnylam Pharmaceuticals, Inc. (Protocol ALN-TTR02-007)